Thrombin Market Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Jan 2018| TMR109A| Transparency

Report Highlights

REPORT DESCRIPTION

Global Thrombin Market: Overview

This report on thrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of thrombin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thrombin market with respect to the leading market segments based on major product segment, dosage form segment, and end users segment.

Global Thrombin Market: Key Segments

Based on the product type, the thrombin market has been segmented into bovine thrombin, human thrombin and recombinant thrombin. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thrombin products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the thrombin market and could influence the market in near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thrombin market.

Global Thrombin Market: Regional Outlook

Geographically, thrombin market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thrombin market.

Companies Mentioned in Report

The report also profiles key players operating in the thrombin market which are Johnson & Johnson, Pfizer, Inc., Mallinckrodt Pharmaceuticals, Shanghai RAAS blood products co., Ltd., Japan Blood Products Organization and Mochida Pharmaceutical Co., Ltd.

The global thrombin market is segmented as follows:

Global Thrombin market, by Product

Bovine Thrombin
Human Thrombin
Recombinant Thrombin
Global Thrombin market, by Dosage Form

Powder Form
Solution Form
Others
Global Thrombin market, by End User

Hospitals
Diagnostics Centers & Clinics
Academics and Research Institutes
Global Thrombin market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of the Europe
Asia Pacific
Japan
China
Australia & New Zealand
Rest of Asia Pacific
Rest of World

  • Table 1 : Global Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 2 : Global Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 2 : Global Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
  • Table 3 : Global Thrombin Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 4 : North America Thrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 5 : North America Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 6 : North America Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
  • Table 7 : North America Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 8 : Europe Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 9 : Europe Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 10 : Europe Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
  • Table 11 : Europe Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 12 : Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 13 : Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 14 : Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
  • Table 15 : Asia Pacific Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 16 : Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 17 : Rest of the World Thrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
  • Table 18 : Rest of the World Thrombin Market Size (US$ Mn) Forecast, by End-user, 2015–2025
  • Table 19 : Johnson & Johnson Services, Inc. Products & Services Offered
  • Table 20 : Pfizer, Inc. Business Overview
  • Table 21 : Mallinckrodt Pharmaceuticals Business Overview
  • Table 22 : Shanghai RAAS blood products co., Ltd. Business Overview
  • Table 23 : Japan Blood Products Organization Business Overview
  • Table 24 : Mochida Pharmaceutical Co., Ltd. Business Overview
  • Table 25 : BIOFAC A/S Business Overview
  • Table 26 : Biomed-Lublin S.A. Business Overview
  • Table 27 : Hualan Biological Engineering, Inc. Business Overview
  • Figure 1 : Global Thrombin Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 2 : Market Value Share, by Region (2016)
  • Figure 3 : Market Value Share, by Product (2016)
  • Figure 4 : Market Value Share, by Dosage Form (2016)
  • Figure 5 : Market Value Share, by End User (2016)
  • Figure 6 : Global Thrombin Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 7 : Global Thrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bovine Thrombin, 2015–2025
  • Figure 8 : Global Thrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Human Thrombin, 2015–2025
  • Figure 9 : Global Thrombin Market Revenue (US$ Mn) and
  • Figure 10 : Global Thrombin Market Attractiveness Analysis, by Product, 2017–2025
  • Figure 11 : Global Thrombin Market Value Share, by Dosage Form, 2016 and 2025
  • Figure 12 : Global Thrombin Market Revenue (US$ Mn), by Powder Form, 2015–2025
  • Figure 13 : Global Thrombin Market Revenue (US$ Mn), by Solution Form, 2015–2025
  • Figure 14 : Global Thrombin Market Revenue (US$ Mn), by Others, 2015–2025
  • Figure 15 : Global Thrombin Market Attractiveness, by Dosage Form, 2015–2025
  • Figure 16 : Global Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
  • Figure 17 : Global Thrombin Market Revenue (US$ Mn), by Human Source, 2015–2025
  • Figure 18 : Global Thrombin Market Revenue (US$ Mn), by Diagnostic Centers & Clinics Source, 2015–2025
  • Figure 19 : Global Thrombin Market Revenue (US$ Mn), by Academic and Research Institutes, 2015–2025
  • Figure 20 : Global Thrombin Market Attractiveness Analysis, by End-user, 2015–2025
  • Figure 21 : Global Thrombin Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 22 : Global Thrombin Market Attractiveness Analysis, by Region, 2015–2025
  • Figure 23 : North America Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 24 : North America Thrombin Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 25 : North America Thrombin Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 26 : North America Thrombin Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 27 : North America Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
  • Figure 28 : North America Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
  • Figure 29 : North America Thrombin Market Attractiveness Analysis, by Product,
  • Figure 30 : North America Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
  • Figure 31 : North America Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 32 : Europe Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 33 : Europe Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 34 : Europe Thrombin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 35 : Europe Thrombin Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 36 : Europe Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
  • Figure 37 : Europe Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
  • Figure 38 : Europe Thrombin Market Attractiveness Analysis, by Product,
  • Figure 39 : Europe Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
  • Figure 40 : Europe Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 41 : Asia Pacific Thrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 42 : Asia Pacific Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 43 : Asia Pacific Thrombin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 44 : Asia Pacific Thrombin Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 45 : Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
  • Figure 46 : Asia Pacific Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
  • Figure 47 : Asia Pacific Thrombin Market Attractiveness Analysis, by Product,
  • Figure 48 : Asia Pacific Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
  • Figure 49 : Asia Pacific Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 50 : Rest of the World Thrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 51 : Rest of the World Thrombin Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 52 : Rest of the World Thrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
  • Figure 53 : Rest of the World Thrombin Market Value Share Analysis, by End-user, 2016 and 2025
  • Figure 54 : Rest of the World Thrombin Market Attractiveness Analysis, by Product,
  • Figure 55 : Rest of the World Thrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
  • Figure 56 : Rest of the World Thrombin Market Attractiveness Analysis, by End-user, 2017–2025
  • Figure 57 : Thrombin Market Heat Map Analysis by Company
  • Figure 58 : Johnson & Johnson Services, Inc. Breakdown of Net Sales (US$ Mn)
  • Figure 59 : Johnson & Johnson Services, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level or Segment Level, 2015–2016
  • Figure 60 : Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Region, 2017
  • Figure 61 : Johnson & Johnson Services, Inc. Breakdown of Net Sales, by Business Segment, 2017
  • Figure 62 : Pfizer Inc. revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
  • Figure 63 : Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level or Segment Level, 2015–2016
  • Figure 64 : Pfizer, Inc. Breakdown of Net Sales (2016), by Region
  • Figure 65 : Pfizer, Inc. Number of Discovery Projects till February 2016
  • Figure 66 : Mallinckrodt Pharmaceuticals Breakdown of Net Sales, by Business Segment, 2016
  • Figure 67 : Mallinckrodt Pharmaceuticals Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
  • Figure 68 : Shanghai RAAS blood products co., Ltd. revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2015
  • Figure 69 : Mochida Pharmaceutical Co., Ltd. revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
  • Figure 70 : Biomed-Lublin S.A. revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2016
  • Figure 71 : Global Thrombin Market Revenue Split, By Product (2016)
  • Figure 72 : Global Thrombin Market Revenue Split, By Dosage Form (2016)
  • Figure 73 : Global Thrombin Market Revenue Split, By Region (2016)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report